[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Views 1,587
Citations 0
Correction
January 24/31, 2017

Incorrect Figures

JAMA. 2017;317(4):442. doi:10.1001/jama.2016.20139

In the Original Investigation entitled “Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial” published in the August 16, 2016, issue of JAMA,1 Figure 3C is changed to reflect extended data markers in the Kaplan-Meier plot indicating time to event, which were cut off 1 month early, thus underrepresenting the final difference between placebo and the active treatment groups. Additionally, in the online supplement, the legend for eFigure 2 has been changed to reflect the geometric mean of ratio. This article was corrected online.

References
1.
Miller  PD, Hattersley  G, Riis  BJ,  et al.  Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial.  JAMA. 2016;316(7):722-733.PubMedGoogle ScholarCrossref
×